Expression-of-Interest for consumer participation on Grant Review Committees for the 2022 Priority-driven Collaborative Cancer Research Scheme

Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (PdCCRS) is an innovative, competitive, annual cancer research projects grant funding scheme. The PdCCRS is conducted by Cancer Australia in partnership with other funders of cancer research.

Cancer Australia and its funding partners value the involvement of people affected by cancer in all aspects of the PdCCRS including the review of research grant applications.
This is an open, national call for Expression-of-Interest from consumers interested in being part of Grant Review Committees for the PdCCRS.

Experience in the review of research grants is desirable; however, these skills are not essential because Cancer Australia will provide the appropriate training. Training will be undertaken over 2 days in Cancer Australia’s Sydney and Melbourne offices in August/September 2022.

Aboriginal and Torres Strait Islanders, individuals from culturally and linguistically diverse backgrounds and male consumers are encouraged to apply.

The Expression-of-Interest form and background information is available on the Cancer Australia website at:
https://www.canceraustralia.gov.au/research/priority-driven-research/consumers-and-grant-review-committees

For further information please contact: Nathan Borg, Project Manager, Research and Clinical Trials, Cancer Australia:
(02) 6217 9805 or Nathan.Borg@canceraustralia.gov.au
Applications close: Wednesday, 25 May 2022.


Download Letter of Assistance


Download Application Form


Download Background Information

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

NECA CEO Meredith Cummins is Now INCA President

Raising awareness of neuroendocrine cancer at Peninsula Bays Hospital Wellness Day

Raising Awareness for NETs on World Cancer Day in WA

Australia delivers excellent cancer care, but not equally

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.